National Eye Institute
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private, Subsidiary
- Established
- 1968-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.nei.nih.gov
Intravenous Immunoglobulin Therapy in Optic Neuritis
Phase 3
Completed
- Conditions
- Optic Neuritis
- First Posted Date
- 1999-09-24
- Last Posted Date
- 2009-09-17
- Lead Sponsor
- National Eye Institute (NEI)
- Registration Number
- NCT00000117
- Locations
- 🇺🇸
Mayo Clinic, Rochester, Minnesota, United States
🇺🇸Mayo Clinic, Department of Neurology, Rochester, Minnesota, United States
Randomized Trial of Vitamin A and Vitamin E Supplementation for Retinitis Pigmentosa
Phase 3
Completed
- Conditions
- Retinitis Pigmentosa
- First Posted Date
- 1999-09-24
- Last Posted Date
- 2009-09-17
- Lead Sponsor
- National Eye Institute (NEI)
- Registration Number
- NCT00000114
Collaborative Corneal Transplantation Studies (CCTS)
Phase 3
Completed
- Conditions
- Corneal TransplantationGraft Rejection
- First Posted Date
- 1999-09-24
- Last Posted Date
- 2009-09-17
- Lead Sponsor
- National Eye Institute (NEI)
- Registration Number
- NCT00000137
Ganciclovir Implant Study for Cytomegalovirus Retinitis
Phase 3
Completed
- Conditions
- HIV InfectionsAcquired Immunodeficiency SyndromeCytomegalovirus Retinitis
- First Posted Date
- 1999-09-24
- Last Posted Date
- 2009-09-17
- Lead Sponsor
- National Eye Institute (NEI)
- Registration Number
- NCT00000118
The Prism Adaptation Study (PAS)
Phase 3
Completed
- Conditions
- Esotropia
- First Posted Date
- 1999-09-24
- Last Posted Date
- 2009-09-17
- Lead Sponsor
- National Eye Institute (NEI)
- Registration Number
- NCT00000121
Randomized Trial of Acetazolamide for Uveitis-Associated Cystoid Macular Edema
Phase 2
Completed
- Conditions
- Macular Edema, Cystoid
- First Posted Date
- 1999-09-24
- Last Posted Date
- 2009-09-17
- Lead Sponsor
- National Eye Institute (NEI)
- Registration Number
- NCT00000115
Herpetic Eye Disease Study (HEDS) I
Phase 3
- Conditions
- Keratitis, HerpeticOcular Herpes Simplex
- First Posted Date
- 1999-09-24
- Last Posted Date
- 2009-09-17
- Lead Sponsor
- National Eye Institute (NEI)
- Registration Number
- NCT00000138
Ischemic Optic Neuropathy Decompression Trial Followup (IONDT Followup)
- Conditions
- Ischemic Optic Neuropathy
- First Posted Date
- 1999-09-24
- Last Posted Date
- 2006-05-26
- Lead Sponsor
- National Eye Institute (NEI)
- Registration Number
- NCT00000126
- Locations
- 🇺🇸
St. Louis University, Anheuser-Busch Eye Institute, St. Louis, Missouri, United States
🇺🇸SUNY Health Science Center, Department of Neurology, Syracuse, New York, United States
🇺🇸Carolinas Medical Center, Charlotte, North Carolina, United States
Krypton-Argon Regression of Neovascularization Study (KARNS)
Phase 3
Completed
- Conditions
- Diabetic RetinopathyRetinal NeovascularizationDiabetes Mellitus
- First Posted Date
- 1999-09-24
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- National Eye Institute (NEI)
- Registration Number
- NCT00000153
The Collaborative Longitudinal Evaluation of Ethnicity and Refractive Error (CLEERE) Study
- Conditions
- Myopia
- First Posted Date
- 1999-09-24
- Last Posted Date
- 2005-06-24
- Lead Sponsor
- National Eye Institute (NEI)
- Registration Number
- NCT00000169
- Locations
- 🇺🇸
University of Houston, College of Optometry, Houston, Texas, United States
🇺🇸West Alabama Health Services, Inc., Eutaw, Alabama, United States
🇺🇸Southern California College of Optometry, Fullerton, California, United States
© Copyright 2025. All Rights Reserved by MedPath